Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2008:481–497. [Article in German] doi: 10.1007/978-3-540-72296-0_38

Pneumonien

S Ewig 6
Editors: Hilmar Burchardi1, Reinhard Larsen2, Ralf Kuhlen3, Karl-Walter Jauch4, Jürgen Schölmerich5
PMCID: PMC7122425

Auszug

Die heute gebräuchlichen Definitionen der unterschiedlichen Formen der Pneumonie haben nicht nur eine begrifflich ordnende Funktion, sondern bezeichnen jeweils spezifische ätiopathogenetische, diagnostische und therapeutische Konzepte. Es kommt ihnen somit ein klinisch handlungsanweisender Wert zu.

Literatur

  • 1.Alves C., Nicolas J.M., Miro J.M., Torres A., Agusti C., Gonzalez J., Rano A., Benito N., Moreno A., Garcia F., Milla J., Gatell J.M. Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J. 2001;17:87–93. doi: 10.1183/09031936.01.17100870. [DOI] [PubMed] [Google Scholar]
  • 2.American Thoracic Society Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–1754. doi: 10.1164/ajrccm.163.7.at1010. [DOI] [PubMed] [Google Scholar]
  • 3.American Thoracic Society Guidelines for the management of adults with hospital-acquierd, ventilator-associated and healthcareassociated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416. doi: 10.1164/rccm.200405-644ST. [DOI] [PubMed] [Google Scholar]
  • 4.Baddour L.M., Yu V.L., Klugman K.P., Feldman C., Ortqvist A., Rello J., Morris A.J., Luna C.M., Snydman D.R., Ko W.C., Chedid M.B., Hui D.S., Andremont A., Chiou C.C., International Pneumococcal Study Group Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004;170:440–444. doi: 10.1164/rccm.200311-1578OC. [DOI] [PubMed] [Google Scholar]
  • 5.Bliziotis I.A., Samonis G., Vardakas K.Z., Chrysanthopoulou S., Falag M.E. Effect of aminoglycoside and ß-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance: A meta-analysis of randomized, controlled trials. Clin Infect Dis. 2005;41:149–158. doi: 10.1086/430912. [DOI] [PubMed] [Google Scholar]
  • 6.British Thoracic Society and the Public Health Laboratory Service Community-acquired pneumonia in adults in British hospitals in 1982–1983: A survey of aetiology, mortality, prognostic factors and cutcome. Q J Med. 1987;239:195–220. [PubMed] [Google Scholar]
  • 7.British Thoracic Society Standards of Care Committee BTS Gui-delines for the Management of Community Acquired Pneumonia in Adults. Thorax. 2001;56(Suppl 4):1–64. doi: 10.1136/thorax.56.suppl_4.iv1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Capelastegui A., Espana P.P., Quintana J.M., Areitio I., Gorordo I., Egurrola M., Bilbao A. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006;27:151–157. doi: 10.1183/09031936.06.00062505. [DOI] [PubMed] [Google Scholar]
  • 9.Chamot E., Boffi EI Amari E., Rohner P., Van Delden C. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother. 2003;47:2756–2764. doi: 10.1128/AAC.47.9.2756-2764.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chastre J., Wolff M., Fagon J.Y., Chevret S., Thomas F., Wermert D., Clementi E., Gonzalez J., Jusserand D., Asfar P., Perrin D., Fieux F., Aubas S., PneumA Trial Group Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588–2598. doi: 10.1001/jama.290.19.2588. [DOI] [PubMed] [Google Scholar]
  • 11.Confalonieri M., Calderini E., Terraciano S., Chidini G., Celeste E., Puccio G., Gregoretti C., Meduri G.U. Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystisjiroveci pneumonia. Intens Care Med. 2002;28:1233–1238. doi: 10.1007/s00134-002-1395-2. [DOI] [PubMed] [Google Scholar]
  • 12.Dennesen P.J., van der Ven A.J., Kessels A.G., Ramsay G., Bonten M.J. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001;163:1371–1375. doi: 10.1164/ajrccm.163.6.2007020. [DOI] [PubMed] [Google Scholar]
  • 13.Ewig S., Schafer H., Rockstroh J.K. Intensive therapy of acute respiratory insufficiency in HIV infected patients. Current decision gui-delines and therapy options. Pneumologie. 1997;51:815–821. [PubMed] [Google Scholar]
  • 14.Ewig S., Ruiz M., Mensa J., et al. Severe community-acquired pneumonia — assessment of severity criteria. Am J Respir Crit Care Med. 1998;158:1102–1108. doi: 10.1164/ajrccm.158.4.9803114. [DOI] [PubMed] [Google Scholar]
  • 15.Ewig S., Torres A., Riquelme R., et al. Pulmonary complications in patients with hematologic malignancies treated at a respiratory ICU. Eur Respir J. 1998;12:116–122. doi: 10.1183/09031936.98.12010116. [DOI] [PubMed] [Google Scholar]
  • 16.Ewig S., Torres A. Severe community-acquired pneumonia: Clin Chest Med. 1999;20:575–587. doi: 10.1016/s0272-5231(05)70237-9. [DOI] [PubMed] [Google Scholar]
  • 17.Ewig S. Validation of diagnostic techniques in ventilator-assisted pneumonia — a critical appraisal. Pneumologie. 1999;53:513–520. doi: 10.1055/s-1999-9045. [DOI] [PubMed] [Google Scholar]
  • 18.Ewig S., Torres A. Flexible bronchoscopy for nosocomial pneumonia. Clin Chest Med. 2000;22:263–279. doi: 10.1016/S0272-5231(05)70042-3. [DOI] [PubMed] [Google Scholar]
  • 19.Fabregas N., Torres A., El-Ebiary M., et al. Histopathological and microbiological aspects of ventilator-associated pneumonia. Anesthesiology. 1996;84:260–271. doi: 10.1097/00000542-199604000-00002. [DOI] [PubMed] [Google Scholar]
  • 20.Gea J., Roca J., Torres A., Agusti A., Wagner R., Rodriguez-Roison R. Mechanisms of abnormal gas exchange in patients with pneumonia. Anesthesiology. 1991;75:782–789. doi: 10.1097/00000542-199111000-00009. [DOI] [PubMed] [Google Scholar]
  • 21.Gibot S., Cravoisy A., Levy B., Bene M.C., Faure G., Bollaert P.E. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. NEnglJ Med. 2004;29(350):451–458. doi: 10.1056/NEJMoa031544. [DOI] [PubMed] [Google Scholar]
  • 22.Hawley P.H., Ronco J.J., Guillemi S.A., et al. Decreasing frequency but worsening mortality of acute respiratory failure secondary to Ai-dsrelated pneumocystisjiroveci pneumonia. Chest. 1994;106:1456–1459. doi: 10.1378/chest.106.5.1456. [DOI] [PubMed] [Google Scholar]
  • 23.Hoffken G., Lorenz J., Kern W., Welte T., Bauer T., Dalhoff K., Dietrich E., Ewig S., Gastmeier P., Grabein B., Halle E., Kolditz M., Marre R., Sitter H. Epidemiologie, Diagnostik, antimikrobielle Therapie und Ma-nagement von erwachsenen Patienten mit ambulant erworbenen tiefen Atemwegsinfektionen (akute Bronchitis, akute Exazerbation einer chronischen Bronchitis, Influenza und andere respiratorische Virusinfektionen) sowie ambulant erworbener Pneumonie. Pneumologie. 2005;59:612–664. doi: 10.1055/s-2005-870988. [DOI] [PubMed] [Google Scholar]
  • 24.Hubmayr R.D., Burchardi H., Elliot M., et al. Intensive Care Med. Chicago: Illionis; 2002. Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia; pp. 1521–1536. [DOI] [PubMed] [Google Scholar]
  • 25.Klibanov O.M., Raasch R.H., Rublein J.C. Single versus combined antibiotic therapy for gram-negative infections. Ann Pharmacother. 2004;38:332–337. doi: 10.1345/aph.1D132. [DOI] [PubMed] [Google Scholar]
  • 26.Leibovici L., Paul M., Poznanski O., Drucker M., Samra Z., Konigsberger H., Pitlik S.D. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother. 1997;41:1127–1133. doi: 10.1128/aac.41.5.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Marquette C.H., Copin M.C., Wallet F., et al. Diagnostic test for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med. 1995;151:1878–1888. doi: 10.1164/ajrccm.151.6.7767535. [DOI] [PubMed] [Google Scholar]
  • 28.Maschmeyer G., Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis. 2000;19:915–925. doi: 10.1007/s100960000410. [DOI] [PubMed] [Google Scholar]
  • 29.Micek S.T., Lloyd A.E., Ritchie D.J., Reichley R.M., Fraser V.J., Kollef M.H. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005;49:1306–1311. doi: 10.1128/AAC.49.4.1306-1311.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Miller R.F., Allen E., Copas A., Singer M., Edwards S.G. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax. 2006;61(8):716–721. doi: 10.1136/thx.2005.055905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Morris A., Wachter R.M., Luce J., Turner J., Huang L. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystisjiroveci pneumonia. AIDS. 2003;17:73–80. doi: 10.1097/00002030-200301030-00010. [DOI] [PubMed] [Google Scholar]
  • 32.Paul M., Soares-Weiser K., Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ. 2003;326:1111–1115. doi: 10.1136/bmj.326.7399.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Paul M., Benuri-Silbiger I., Soares-Weiser K., Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ. 2004;328:668–672. doi: 10.1136/bmj.38028.520995.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Paul M, Silbiger I, Grozinsky S, Soares-Weiser K, Leibovici L (2006) Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst RevCD003344 [DOI] [PubMed]
  • 35.Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic »blind« bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121–1129. doi: 10.1164/ajrccm/143.5_Pt_1.1121. [DOI] [PubMed] [Google Scholar]
  • 36.Rello J., Torres A. Microbial causes of ventilator-associoated pneumonia. Semin Respir Infect. 1996;11:24–31. [PubMed] [Google Scholar]
  • 37.Rello J., Ausina V., Ricart M., Castella J., Prats G. Impact of previous antimicrobial therapy on theetiology and outcome of ventilator-associated pneumonia. Chest. 1993;104:1230–1235. doi: 10.1378/chest.104.4.1230. [DOI] [PubMed] [Google Scholar]
  • 38.Rodriguez-Roisin R., Roca J. Update, 96 on pulmonary gas exchange pathophysiology in pneumonia. Semin Respir Infect. 1996;11:3–12. [PubMed] [Google Scholar]
  • 39.Rubin R(1989) Infection in the renal and liver transplant Patient. In: Rubin R, Young LS (eds) Clinical approach to infection in the compromised host, 2nd edn. Plenum Medical Book, New York London, pp 557–621
  • 40.Safdar N., Handelsman J., Maki D.G. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis. 2004;4:519–527. doi: 10.1016/S1473-3099(04)01108-9. [DOI] [PubMed] [Google Scholar]
  • 41.Singh N., Rogers P., Atwood C.W., Wagener M.M., Yu V.L. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505–511. doi: 10.1164/ajrccm.162.2.9909095. [DOI] [PubMed] [Google Scholar]
  • 42.Torres A., Serra-Batlles J., Ferrer A., et al. Severe community acquired pneumonia. Epidemiology and prognosis factors. Am Rev Respir Dis. 1991;114:312–318. doi: 10.1164/ajrccm/144.2.312. [DOI] [PubMed] [Google Scholar]
  • 43.Torres A., Ewig S. Diagnosing ventilator-associated pneumonia. NEnglJ Med. 2004;350:433–455. doi: 10.1056/NEJMp038219. [DOI] [PubMed] [Google Scholar]
  • 44.Wachter R.M., Russi M.B., Bloch D.A., Hopewell P.C., Luce J.M. Pneumocystis jiroveci pneumonia and respiratory failure in AIDS. Improved outcomes and increased use of intensive care units. Am Rev Respir Dis. 1991;143:251–251. doi: 10.1164/ajrccm/143.2.251. [DOI] [PubMed] [Google Scholar]
  • 45.Woodhead M., Blasi F., Ewig S., Huchon G., Ieven M., Ortqvist A., Schaberg T., Torres A., van der Heijden G., Verheij T.J., European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases Guidelines for the management of adult lower respiratory tract infections Eur Respir J. 2005;26:1138–1180. doi: 10.1183/09031936.05.00055705. [DOI] [PubMed] [Google Scholar]
  • 46.Johanson W.G., Pierce A.K., Sandford J.P., Thomas G.D. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701–706. doi: 10.7326/0003-4819-77-5-701. [DOI] [PubMed] [Google Scholar]

Articles from Die Intensivmedizin are provided here courtesy of Nature Publishing Group

RESOURCES